PAR1 is a thrombin-responsive GPR and its stimulation causes an enhancement in MALT1 protease activity in both osteosarcoma and breast cancer cells, potentially associating with other aggressive phenotypes [22]. Here, MALT1 is linked to breast carcinoma.